Josh Levitsky MD, MS

Northwestern University


Appearances

  • Topic #4 (Liver)
  • Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights
  • Overview of immunosuppression in liver transplant recipients
  • Living Donor Issues: Liver
  • Deceased Donor Management and Organ Preservation
  • Panel Discussion: Overview of Current Allocation by Organ - How Can We Increase Deceased Donor Utilization?
  • Renal Dysfunction in Non-Kidney Organ Transplants: Liver, Heart, Lung
  • Management of DSA Across all Organ Transplants
  • With All Our Drugs, Why Can’t We Develop Evidence-based, Individualized Immunosuppression
  • Controversies in Liver-Kidney (2019)
  • Deceased Donor Management and Organ Preservation: Who does it best? Kidney Preservation, Liver Perfusion, Ex Vivo Lung
  • Overview of Current Allocation by Organ - How Can We Increase Deceased Donor Utilization?
  • Key Clinical Trials in Heart, Lung, and Liver
  • Transplant Trivia!
  • Case Studies: Navigating Equity and Utility in the Real World - Option 1 (Liver and Kidney)
  • Session 6: Option 1: Liver Track - Immunosuppression Monitoring and Endpoints